2020•Zhonghua gan-dan waike zazhiRequires access

Precise treatment of intrahepatic cholangiocarcinoma

Xiao Huan Liang, Liye Tao

Open publisher page 0 citations

Abstract

Although surgical resection is currently recognized as the only effective treatment for intrahepatic cholangiocarcinoma (ICC), it is extremely difficult to diagnose because there are no obvious clinical symptoms at the early stage. Patients are often diagnosed at the advanced stage and the lesion cannot be resected which leads to limited systemic chemotherapy. So the mortality is still high. Accurate treatment is a hot topic in the medical field, and more and more attentions have been paid to enhance the treatments of patients. This article reviewed the issues related to surgical treatment, chemotherapy, molecular targeted therapy, and immunotherapy in patients with ICC, and focuses on the latest progress of molecular targeted therapy. Key words: Bile duct neoplasms; Intrahepatic cholangiocarcinoma; Precise treatment; Molecular targeted therapy

About this research paper

What this paper is about

Although surgical resection is currently recognized as the only effective treatment for intrahepatic cholangiocarcinoma (ICC), it is extremely difficult to diagnose because there are no obvious clinical symptoms at the early stage. Patients are often diagnosed at the advanced stage and the lesion cannot be resected which leads to limited systemic chemotherapy. So the mortality is still high. Accurate treatment is a hot topic in the medical field, and more and more attentions have been paid to enhance the treatments of patients. This article reviewed the issues related to surgical treatment, chemotherapy, molecular targeted therapy, and immunotherapy in patients with ICC, and focuses on the latest progress of molecular targeted therapy. Key words: Bile duct neoplasms; Intrahepatic cholangiocarcinoma; Precise treatment; Molecular targeted therapy

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Although surgical resection is currently recognized as the only effective treatment for intrahepatic cholangiocarcinoma (ICC), it is extremely difficult to diagnose because there are no obvious clinical symptoms at the early stage. Patients are often diagnosed at the advanced stage and the lesion cannot be resected which leads to limited systemic chemotherapy. So the mortality is still high. Accurate treatment is a hot topic in the medical field, and more and more attentions have been paid to enhance the treatments of patients. This article reviewed the issues related to surgical treatment, chemotherapy, molecular targeted therapy, and immunotherapy in patients with ICC, and focuses on the latest progress of molecular targeted therapy. Key words: Bile duct neoplasms; Intrahepatic cholangiocarcinoma; Precise treatment; Molecular targeted therapy

Key concepts: Intrahepatic Cholangiocarcinoma, Medicine, Chemotherapy, Stage (stratigraphy), Targeted therapy, Immunotherapy, Bile duct, Intrahepatic bile ducts

Related papers

Back to paper searchBrowse research topicsOriginal source
Precise treatment of intrahepatic cholangiocarcinoma — Research Paper | ScholarLens